BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 33430864)

  • 21. Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass grafting: a propensity score matching study.
    Ma X; Dong R; Chen P; Zhao Y; Zeng C; Xin M; Ye Q; Wang J
    BMC Cardiovasc Disord; 2020 Apr; 20(1):159. PubMed ID: 32252636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of successful chronic total occlusion percutaneous coronary intervention on long-term clinical outcomes in real world.
    Gong X; Zhou L; Ding X; Chen H; Li H
    BMC Cardiovasc Disord; 2021 Apr; 21(1):182. PubMed ID: 33858349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2014 Apr; 7(4):354-61. PubMed ID: 24630886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous coronary intervention vs coronary artery bypass grafting for left main coronary artery disease? A systematic review and meta-analysis of randomized controlled trials.
    Sharma SP; Dahal K; Khatra J; Rosenfeld A; Lee J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28371437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Survival After Surgical or Percutaneous Revascularization in Patients With Diabetes and Multivessel Coronary Disease.
    Tam DY; Dharma C; Rocha R; Farkouh ME; Abdel-Qadir H; Sun LY; Wijeysundera HC; Austin PC; Udell JA; Gaudino M; Fremes SE; Lee DS
    J Am Coll Cardiol; 2020 Sep; 76(10):1153-1164. PubMed ID: 32883408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of diabetes mellitus on patients with unprotected left main coronary artery lesion disease treated with either percutaneous coronary intervention or coronary-artery bypass grafting.
    Luo Y; Yu X; Chen F; Du X; He J; Gao Y; Zhang X; Zhang Y; Ren X; Lv S; Ma C
    Coron Artery Dis; 2012 Aug; 23(5):322-9. PubMed ID: 22750912
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease.
    Zheng Z; Xu B; Zhang H; Guan C; Xian Y; Zhao Y; Fan H; Yang Y; Wang W; Gao R; Hu S
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1102-11. PubMed ID: 27282597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.
    Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW
    Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score.
    Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW
    Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Successful revascularization versus medical therapy in diabetic patients with stable right coronary artery chronic total occlusion: a retrospective cohort study.
    Yan Y; Zhang M; Yuan F; Liu H; Wu D; Fan Y; Guo X; Xu F; Zhang M; Zhao Q; Lyu S
    Cardiovasc Diabetol; 2019 Aug; 18(1):108. PubMed ID: 31434572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
    Holm NR; Mäkikallio T; Lindsay MM; Spence MS; Erglis A; Menown IBA; Trovik T; Kellerth T; Kalinauskas G; Mogensen LJH; Nielsen PH; Niemelä M; Lassen JF; Oldroyd K; Berg G; Stradins P; Walsh SJ; Graham ANJ; Endresen PC; Fröbert O; Trivedi U; Anttila V; Hildick-Smith D; Thuesen L; Christiansen EH;
    Lancet; 2020 Jan; 395(10219):191-199. PubMed ID: 31879028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of SYNTAX Score on 10-Year Outcomes After Revascularization for Left Main Coronary Artery Disease.
    Yoon YH; Ahn JM; Kang DY; Park H; Cho SC; Lee PH; Lee SW; Park SW; Park DW; Park SJ
    JACC Cardiovasc Interv; 2020 Feb; 13(3):361-371. PubMed ID: 32029254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical Versus Percutaneous Coronary Revascularization in Patients With Diabetes and Acute Coronary Syndromes.
    Ramanathan K; Abel JG; Park JE; Fung A; Mathew V; Taylor CM; Mancini GBJ; Gao M; Ding L; Verma S; Humphries KH; Farkouh ME
    J Am Coll Cardiol; 2017 Dec; 70(24):2995-3006. PubMed ID: 29241487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Long-term Outcomes in Patients with Premature Triple-vessel Coronary Disease Undergoing Three Different Treatment Strategies: A Prospective Cohort Study.
    Xu JJ; Zhang Y; Jiang L; Tian J; Song L; Gao Z; Feng XX; Zhao XY; Zhao YY; Wang D; Sun K; Xu LJ; Liu R; Gao RL; Xu B; Song L; Yuan JQ
    Chin Med J (Engl); 2018 Jan; 131(1):1-9. PubMed ID: 29271373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term trends of treatment effect of stenting or bypass surgery in patients with ostial or shaft left main coronary artery disease.
    Yoon YH; Lee PH; Ahn JM; Kang DY; Park H; Kwon O; Lee K; Lee SW; Park DW; Park SJ;
    Catheter Cardiovasc Interv; 2019 Sep; 94(3):315-322. PubMed ID: 30724018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparing clinical outcomes in patients with diabetes undergoing coronary artery bypass graft and percutaneous coronary intervention in real world practice in Iranian population.
    Arabi A; Naghshtabrizi B; Baradaran HR; Moradi Y; Asadi-Lari M; Mehrakizadeh A
    BMC Cardiovasc Disord; 2022 Mar; 22(1):75. PubMed ID: 35240990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term outcomes of in-hospital staged revascularization versus culprit-only intervention for patients with ST-segment elevation myocardial infarction and multivessel disease.
    Cui K; Lyu S; Song X; Liu H; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Dai J; Tian J
    Coron Artery Dis; 2019 May; 30(3):188-195. PubMed ID: 30724818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.